Cedric Francois, Apellis CEO (Optum via YouTube)
Apellis, Beam team up to test base editing against the broad field of complement disorders
Last summer, as Apellis was preparing for the approval of its potential blockbuster PNH drug Empaveli, CEO Cedric Francois sat down with his team …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
